Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

100643-71-8

Desloratadine

100643-71-8
386750-22-7

Desvenlafaxine succinate H2O

386750-22-7
138530-94-6

Dexlansoprazole

138530-94-6
13739-02-1

Diacerein

13739-02-1
53-43-0

Dehydroepiandrosterone

53-43-0
3736-81-0

Diloxanide Furoate

3736-81-0
33286-22-5

Diltiazem HCl

33286-22-5
523-87-5

Dimenhydrinate

523-87-5
363-24-6

Dinoprostone

363-24-6
76584-70-8

Divalproex Sodium

76584-70-8
49745-95-1

Dobutamine HCl

49745-95-1
57808-66-9

Domperidone

57808-66-9
58-73-1

Diphenhydramine

58-73-1
1672-46-4

Digoxigenin

1672-46-4
05/09/3737

Disopyramide

05/09/3737
66-76-2

Dicoumarol

66-76-2
302964-24-5

Dasatinib Hydrate Impurity H

302964-24-5
120013-84-5

rac-(cis/trans) Donepezil N-Oxide

120013-84-5
896134-06-8

2,3-Dihydro-5,6-dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1H-inden-1-one

896134-06-8
2097683-67-3

3-Hydroxy Donepezil

2097683-67-3